Cargando…

“Real‐World” Comparison of Prasugrel With Ticagrelor in Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention in the United States

OBJECTIVES: The 30‐day clinical outcomes with prasugrel or ticagrelor were compared using a US payer database in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI). BACKGROUND: Prasugrel and ticagrelor demonstrated superior efficacy with increased non‐cor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Larmore, Cynthia, Effron, Mark B., Molife, Cliff, DeKoven, Mitch, Zhu, Yajun, Lu, Jingsong, Karkare, Swapna, Lieu, Hsiao D., Lee, Won Chan, Vetrovec, George W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2015
Materias:	Coronary Artery Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215531/ https://www.ncbi.nlm.nih.gov/pubmed/26577386 http://dx.doi.org/10.1002/ccd.26279

Ejemplares similares

Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention: Insights from the GLOBAL LEADERS trial
por: Ono, Masafumi, et al.
Publicado: (2022)

Risks and benefits of percutaneous coronary intervention in spontaneous coronary artery dissection
por: Kotecha, Deevia, et al.
Publicado: (2021)

Long-term survival after coronary bypass surgery and percutaneous coronary intervention
por: Mølstad, Per, et al.
Publicado: (2016)

Device entrapment during percutaneous coronary intervention
por: Sanz‐Sánchez, Jorge, et al.
Publicado: (2022)

Primary percutaneous coronary intervention for ST elevation myocardial infarction in nonagenarians
por: Petroni, Thibaut, et al.
Publicado: (2016)

Using patient-reported outcome measures for primary percutaneous coronary intervention
por: Kwong, Esther, et al.
Publicado: (2019)

Contemporary percutaneous management of coronary calcification: current status and future directions
por: Hennessey, Breda, et al.
Publicado: (2023)

Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents in patients with multivessel coronary artery disease compared to coronary artery bypass surgery five-years after intervention
por: Krenn, Lisa, et al.
Publicado: (2014)

Impact of proctoring on success rates for percutaneous revascularisation of coronary chronic total occlusions
por: Sharma, Vinoda, et al.
Publicado: (2015)

Infarct size and left ventricular remodelling after preventive percutaneous coronary intervention
por: Mangion, Kenneth, et al.
Publicado: (2016)

Coronary artery aneurysms: outcomes following medical, percutaneous interventional and surgical management
por: Khubber, Shameer, et al.
Publicado: (2021)

Viability and functional recovery after chronic total occlusion percutaneous coronary intervention
por: Schumacher, Stefan P., et al.
Publicado: (2021)

Prevention of contrast induced nephropathy by ischemic preconditioning in patients undergoing percutaneous coronary angiography
por: Elserafy, Ahmed Shawky, et al.
Publicado: (2018)

Benefit of primary percutaneous coronary interventions in the elderly with ST segment elevation myocardial infarction
por: Fernández-Bergés, Daniel, et al.
Publicado: (2020)

Percutaneous coronary intervention for left main stem disease: Impact of diabetes mellitus on mortality
por: Bawamia, Bilal R., et al.
Publicado: (2020)

Timing of Impella implantation and outcomes in cardiogenic shock or high‐risk percutaneous coronary revascularization
por: Tarantini, Giuseppe, et al.
Publicado: (2021)

Role of endothelin in microvascular dysfunction following percutaneous coronary intervention for non-ST elevation acute coronary syndromes: a single-centre randomised controlled trial
por: Guddeti, Raviteja R, et al.
Publicado: (2016)

Fractional flow reserve versus angiography for guiding percutaneous coronary intervention: a meta-analysis
por: Zhang, Dongfeng, et al.
Publicado: (2015)

Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic
por: Mohammad, Moman A, et al.
Publicado: (2020)

Trade-off of major bleeding versus myocardial infarction on mortality after percutaneous coronary intervention
por: Ng, Andrew Kei-Yan, et al.
Publicado: (2022)

Long-term impact of baseline anaemia on clinical outcomes following percutaneous coronary intervention in stable angina
por: Davidsen, Line, et al.
Publicado: (2020)

Impact of extracardiac vascular disease on outcomes of 1.4 million patients undergoing percutaneous coronary intervention
por: Bashar, Hussein, et al.
Publicado: (2022)

Association of adoption of transradial access for percutaneous coronary intervention in ST elevation myocardial infarction with door‐to‐balloon time
por: Huded, Chetan P., et al.
Publicado: (2020)

Impact of the residual SYNTAX score on clinical outcomes after percutaneous coronary intervention for patients with chronic renal insufficiency
por: Yan, Liqiu, et al.
Publicado: (2019)

Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus
por: Noman, Awsan, et al.
Publicado: (2016)

Sex differences in time to primary percutaneous coronary intervention and outcomes in patients presenting with ST‐segment elevation myocardial infarction
por: Savage, Michael L., et al.
Publicado: (2022)

Recovery of myocardial perfusion after percutaneous coronary intervention of chronic total occlusions is comparable to hemodynamically significant non‐occlusive lesions
por: Schumacher, Stefan P., et al.
Publicado: (2018)

Reduction of door‐to‐balloon time in patients with ST‐elevation myocardial infarction by single‐catheter primary percutaneous coronary intervention method
por: Lee, Kyong Hee, et al.
Publicado: (2021)

Is the folk medicine known as “The Secret” efficient in reducing bleeding after percutaneous coronary procedures?: a double-blinded, randomised trial
por: Ferry, Charlie, et al.
Publicado: (2022)

Lower coronary plaque burden in patients with HIV presenting with acute coronary syndrome
por: O'Dwyer, E J, et al.
Publicado: (2016)

Sex differences in impact of coronary artery calcification to predict coronary artery disease
por: Nakao, Yoko M, et al.
Publicado: (2018)

Coronary artery calcium progression after coronary artery bypass grafting surgery
por: Abazid, Rami M, et al.
Publicado: (2021)

Prognostic Impact of Nonobstructive Coronary Artery Disease Detected by Coronary Computed Tomographic Angiography
por: Košuta, Daniel, et al.
Publicado: (2021)

Efficacy of cilostazol on platelet reactivity and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: insights from a meta-analysis of randomised trials
por: Bangalore, Sripal, et al.
Publicado: (2014)

Predictive Value of the Acute-to-Chronic Glycemic Ratio for In-Hospital Outcomes in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention
por: Gao, Side, et al.
Publicado: (2019)

Percutaneous coronary intervention versus medical therapy in patients with angina and grey-zone fractional flow reserve values: a randomised clinical trial
por: Hennigan, Barry, et al.
Publicado: (2020)

Pre-test characteristics of unstable angina patients with obstructive coronary artery disease confirmed by coronary angiography
por: Fladseth, Kristina, et al.
Publicado: (2018)

Stent underexpansion due to heavy coronary calcification resistant to rotational atherectomy: A case for coronary lithoplasty?
por: Tovar Forero, Maria Natalia, et al.
Publicado: (2019)

Coronary wave intensity patterns in stable coronary artery disease: influence of stenosis severity and collateral circulation
por: deMarchi, Stefano F, et al.
Publicado: (2019)

No-reflow phenomenon and comparison to the normal-flow population postprimary percutaneous coronary intervention for ST elevation myocardial infarction: case–control study (NORM PPCI)
por: Rossington, Jennifer Ann, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8tqup0v8m17ei1gnd72sje07dr